Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iteos Therapeutics Inc (NQ: ITOS ) 16.25 -0.41 (-2.46%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Iteos Therapeutics Inc iTeos to Participate in Upcoming Investor Conferences August 28, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024 August 20, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer August 05, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK July 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer June 17, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates May 10, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Therapeutics Announces $120 Million Registered Direct Offering May 10, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024 April 07, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors March 06, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates March 06, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024 March 05, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Participate in Upcoming Investor Conferences March 01, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Announces 2024 Strategic Priorities and Anticipated Milestones January 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference November 21, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates November 07, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Participate in Upcoming Investor Conferences September 06, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates August 08, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action June 08, 2023 FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making... Via FinancialNewsMedia iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates May 10, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates March 15, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at Cowen 43rd Annual Health Care Conference February 28, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at SVB Securities Global Biopharma Conference February 07, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Provides Business Updates and Clinical Development Plans for 2023 January 09, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference January 03, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference November 22, 2022 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates November 10, 2022 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference August 02, 2022 From iTeos Therapeutics Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
